MyAverix Finance
US · Healthcare
Solanbridge Group Inc (SLNX)
Drug Manufacturers - Specialty & Generic
Solanbridge Group Inc (SLNX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SLNX
Solanbridge Group Inc (SLNX) — FAQ
What is SLNX's P/E ratio?
The price-to-earnings (P/E) ratio for Solanbridge Group Inc (SLNX) is 18.00 (data as of 2026-05-23).
Does Solanbridge Group Inc pay a dividend?
Dividend yield is not available in the current snapshot for Solanbridge Group Inc (SLNX). Check the MyAverix Finance app for the latest dividend data.
What sector is Solanbridge Group Inc in?
Solanbridge Group Inc (SLNX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is SLNX listed on?
SLNX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.